ESC 365 - Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? - Chat Moderator.

ESC Premium Access

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? - Chat Moderator.

Session: Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

4 more presentations in this session

Prophylactic ablation of preexcitation: when and for whom?

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Treatment of asymptomatic PVCs: when should it be attempted?

Speaker: Professor T. Reichlin (Bern, CH)

What is the optimal treatment of asymptomatic patients with primary electrical syndromes?

Speaker: Professor K. Haugaa (Oslo, NO)

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? – discussion.

Access the full session

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?

Speakers: Professor J. Brugada Terradellas, Professor T. Reichlin, Professor K. Haugaa

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources